Smith & Nephew
SN
$226.93
+0.19%
SharkNinja, Inc. is a product design and technology company that develops and markets small household appliances across five core categories — Cleaning (vacuums and floor care), Cooking and Beverage, Food Preparation, Home Environment, and Beauty — sold primarily under the Shark and Ninja brands in the U.S., Europe, and other international markets. The company occupies a distinctive position as a consumer-insurgent brand builder rather than a legacy appliance manufacturer, using rapid product iteration, direct-to-consumer and social-commerce channels, and aggressive category expansion to take share from incumbents in mature categories. The current investor narrative centers on the durability of its growth algorithm: Q3 2026 revenue rose 21.2% year over year to $1.98 billion with a step-up in gross margin to 59.2%, prompting management to raise guidance and analysts to frame the stock as a compounding growth story rather than a cyclical appliance play. Recent coverage has highlighted the company's use of a one-time tariff refund to fund high-return growth initiatives and its traction with younger customers through social commerce, reinforcing the debate over whether the current pace of share gains and margin expansion is structural or merely a favorable cyclical window.…
SN
Smith & Nephew
$226.93
Related headlines
Investment Opinion: Should I buy SN Today?
Rating: Buy, but a disciplined, staged one. The core thesis is that SharkNinja is an earnings-driven compounder whose trailing PE compressed to 22.5x even as the stock rallied 142.6% over the past year, because Q3 2026 net income of $338.4 million (17.1% net margin) grew far faster than the share price — and with a unanimous 14-Buy/0-Hold/0-Sell consensus, a 1.14 recommendation mean, and a $230.91 average target, the sell-side is aligned with that view. The caveat is that at $222.95 the average target implies only +3.6% upside, so the rating rests on the $300 high target (34.6% upside) being the right anchor rather than the consensus mean.
The supporting evidence is unusually strong on the operating line: Q3 2026 revenue of $1.976 billion rose 21.2% YoY, accelerating from 15.6% in Q1 and 22.2% in Q2; gross margin stepped up to 59.2% from 49.8% a year earlier, lifting operating margin to 22.4% from 16.6%; trailing PE of 22.5x against a 0.39 PEG and 2.47x PS frames the stock as inexpensive on a growth-adjusted basis; and TTM free cash flow of $506.1 million remains positive despite the -$209.7 million Q3 print. The balance sheet supports the thesis — debt-to-equity of 0.337, a 2.04 current ratio, and >40x interest coverage ($442.9 million operating income versus $11.0 million interest expense) — and ROE of 26.2% confirms high returns on capital.
The risks that could invalidate this are, first, margin durability: if the 59.2% gross margin reverts toward the 49.0% TTM run-rate as the one-time tariff refund laps, trailing EPS falls and the effective multiple rises toward the 28.1x forward PE, which is the more honest anchor. Second, cash conversion: the $632.1 million working-capital build (receivables +$534.5 million, inventory +$294.8 million) must reverse in Q4 or the 24.9x price-to-cash-flow ratio becomes a problem. Third, positioning: at 98.0% of the 52-week range with a beta of 1.171 and a 25.7% max drawdown already seen in September, the stock has no margin of safety. This Buy would downgrade to Hold if gross margin prints below 55% in Q4 or if revenue growth decelerates below 15%, and would upgrade in conviction if Q4 confirms gross margin above 57% with positive free cash flow. Verdict: fairly valued to modestly undervalued on trailing earnings and growth-adjusted metrics, but fully valued on forward earnings — a buy for growth investors with a multi-year horizon, not a value entry.
Sign up to view all
SN 12-Month Price Forecast
The forward view is constructive but not complacent: the operating momentum is genuine, with revenue growth accelerating to 21.2% and operating margin expanding to 22.4% from 16.6%, and the valuation has actually cheapened on trailing earnings even as the stock rallied. The problem is that the market has already capitalized much of this — at 98.0% of the 52-week range with only +3.6% upside to the average target, the risk/reward is asymmetric unless the $300 high target is the right anchor, which requires gross margin to hold near 59%. The 28.1x forward PE exceeding the 22.5x trailing PE is the single most important signal: the market itself expects earnings to normalize lower, so the base case (55% probability) of consolidation near $225-$245 is the most likely outcome. I would upgrade to high confidence if Q4 confirms gross margin above 57% with positive free cash flow, and downgrade to neutral if gross margin prints below 55% or revenue growth falls below 15%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Smith & Nephew's 12-month outlook, with a consensus price target around $249.17 and implied upside of +9.8% versus the current price.
Average Target
$249.17
14 analysts
Implied Upside
+9.8%
vs. current price
Analyst Count
14
covering this stock
Price Range
$214 - $300
Analyst target range
Coverage is broad and uniformly bullish: 13 analysts contribute to the consensus, with a 14 Buy / 0 Hold / 0 Sell distribution (one firm counted separately), a recommendation mean of 1.14 on a 1-to-5 scale, and a consensus rating of "strong_buy." The average target price of $230.91 implies roughly +3.6% upside from the current $222.95, a modest gap that reflects how quickly the stock has run past prior targets rather than any lack of conviction — the consensus EPS estimate of $11.67 and revenue estimate of $11.12 billion for the forward period imply continued double-digit growth that the average target only partially capitalizes. The bullish tilt is corroborated by the institutional ratings flow, which shows repeated reaffirmations at Buy/Overweight from BTIG, JP Morgan, Piper Sandler, TD Cowen, Guggenheim, and Canaccord Genuity through August, October, and early November 2026, with no downgrades in the visible record. The target range of $195.67 to $300.00 is wide — the high target is 53% above the low and 34.6% above the current price — signaling genuine disagreement about the durability of the margin expansion and growth rate rather than a tightly clustered consensus. The $300 high target likely assumes sustained 20%+ revenue growth, gross margins holding near the Q3 2026 level of 59.2%, and multiple expansion as the market reclassifies SharkNinja from appliance maker to premium consumer platform; the $195.67 low target, which sits about 12% below the current price, likely prices in normalization of the tariff-refund benefit, gross margin reversion toward the high-40s, and a slower international rollout. The tight clustering of recent ratings around Buy with no negative actions suggests strong conviction in the near term, but the wide price-target spread and the stock's position at 98% of its 52-week range mean the risk/reward is asymmetric — upside to the average target is small while downside to the low target is meaningful, making the high target the key variable to monitor.
Bulls vs Bears: SN Investment Factors
The bull case currently holds stronger evidence: revenue growth re-accelerated to 21.2%, gross margin expanded ~950bp to 59.2%, and the trailing PE compressed to 22.5x despite a 142.6% one-year rally — a signature of earnings-driven rather than multiple-driven returns, reinforced by a unanimous 14-Buy analyst consensus. The bear case rests less on fundamentals than on positioning and durability: the stock trades at 98% of its 52-week range with only +3.6% upside to the average target, the forward PE (28.1x) exceeds the trailing PE (22.5x), and Q3 free cash flow was -$209.7 million on a large working-capital build. The single most important tension is whether the Q3 margin surge is structural or a one-time tariff-refund artifact — if gross margin holds near 59%, the stock is a re-rating compounder; if it reverts toward 49%, the forward multiple is the honest anchor and the stock is fully valued. The wide $195.67–$300.00 target spread (53% between low and high) confirms this is the key variable the market is debating.
Bullish
- Revenue growth re-accelerating to 21.2%: Q3 2026 revenue of $1.976 billion rose 21.2% YoY from $1.630 billion, up from 15.6% growth in Q1 and 22.2% in Q2, showing the growth algorithm is accelerating rather than fading. Consensus forward revenue of $11.12 billion implies the market expects this pace to persist.
- Gross margin step-up to 59.2%: Q3 2026 gross margin of 59.2% expanded roughly 950 basis points from 49.8% a year earlier, lifting operating margin to 22.4% from 16.6%. Even if part of this reflects a one-time tariff refund, the underlying TTM gross margin of 49.0% is already trending upward.
- Earnings-driven returns compress valuation: The trailing PE fell from 41.4x at Q2 2026 to 22.5x at Q3 2026 even as the stock rallied 142.6% over the year, meaning earnings grew faster than the share price. A 0.39 PEG ratio frames the stock as inexpensive on a growth-adjusted basis.
- Unanimous strong-buy analyst consensus: All 14 covering analysts rate SN Buy with zero Hold or Sell ratings and a recommendation mean of 1.14, with repeated reaffirmations from BTIG, JP Morgan, Piper Sandler, and others through November 2026. The $300 high target implies 34.6% upside from $222.95.
Bearish
- Pinned to highs with minimal upside to target: At $222.95 the stock sits at 98.0% of its 52-week range ($83.21–$225.69), and the $230.91 average target implies only +3.6% upside. The risk/reward is asymmetric: small upside to consensus versus ~12% downside to the $195.67 low target.
- Forward PE exceeds trailing PE: The 28.1x forward PE sits above the 22.5x trailing PE, an inversion implying the market expects earnings to normalize lower from the tariff-refund-boosted Q3 level. If gross margin reverts toward the 49% run-rate, trailing EPS falls and the effective multiple rises.
- Negative Q3 free cash flow: Q3 2026 operating cash flow was -$168.1 million and free cash flow -$209.7 million on a $632.1 million working-capital build (receivables +$534.5M, inventory +$294.8M). The 24.9x price-to-cash-flow ratio looks elevated given this volatility, though TTM FCF remains positive at $506.1 million.
- Margin surge may be transient: The ~950bp gross margin jump likely reflects a one-time tariff refund, favorable mix, and pricing rather than a structural reset. Q2 2026 net margin was just 7.4% versus 17.1% in Q3, illustrating how quickly profitability can swing quarter to quarter.
SN Technical Analysis
SharkNinja is in a powerful, sustained uptrend: the stock is up 142.6% over the past year and 95.8% year to date, and at $222.95 it trades at roughly 98.0% of its 52-week range of $83.21 to $225.69 — essentially pinned to all-time highs. That positioning signals strong momentum and institutional accumulation rather than a value opportunity, but it also means the stock offers little margin of safety and is vulnerable to sharp mean-reversion if momentum stalls. The 25.7% maximum drawdown over the period shows the trend has not been linear, with a notable September air pocket from the $192.49 late-August peak down to $160.80 on September 11 before the recovery resumed. Short-term momentum is accelerating rather than fading: the stock gained 20.4% over the past month and 20.2% over three months, with the one-month gain nearly matching the three-month gain, implying the bulk of the move is recent. Relative strength versus the S&P 500 is extreme — +25.4 percentage points over one month and +133.0 points over one year, against a flat-to-negative SPY (-4.99% one month, +9.59% one year) — confirming this is a market leader in a weak tape, though such divergence often precedes consolidation. The November 6 close of $222.95 came on a 2.68% single-day advance from $217.13, and the sequence of higher highs through late October and early November ($209.12 on October 29, $213.22 on November 2, $219.25 on November 4) suggests buyers remain in control into the print. Key resistance sits at the 52-week high of $225.69, roughly 1.2% above the current price; a clean breakout would likely require a volume-confirmed catalyst and would extend the trend into blue-sky territory, while failure there risks a pullback toward the $190–$200 shelf established in mid-to-late October. Support is layered at the $180 area (the August consolidation zone) and, more distantly, the $160.80 September low, with the 52-week low of $83.21 now more than 60% below the current price and functionally irrelevant as near-term support. With a beta of 1.171, the stock is about 17% more volatile than the market, meaning position sizing should account for amplified drawdowns — the 25.7% max drawdown is a realistic stress case even within an intact uptrend.
Beta
1.17
1.17x market volatility
Max Drawdown
-25.7%
Largest decline past year
52-Week Range
$83-$233
Price range past year
Annual Return
+146.2%
Cumulative gain past year
| Period | SN Return | S&P 500 |
|---|---|---|
| 1m | +19.4% | -2.4% |
| 3m | +20.3% | -2.3% |
| 6m | +114.8% | +2.8% |
| 1y | +146.2% | +11.3% |
| ytd | +99.3% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SN Fundamental Analysis
Revenue growth is strong and re-accelerating: Q3 2026 revenue of $1.976 billion rose 21.2% year over year from $1.630 billion in Q3 2025, following $1.765 billion in Q2 2026 (+22.2% YoY versus $1.445 billion) and $1.413 billion in Q1 2026 (+15.6% YoY versus $1.222 billion), so the growth rate has climbed from the mid-teens to the low-20s across the year. The Q3 segment mix shows Cleaning at $617.2 million, Cooking and Beverage at $597.7 million, Food Preparation at $485.5 million, and Beauty and Home Environment at $276.1 million — a diversified portfolio with no single category above roughly 31% of revenue, which reduces dependence on any one product cycle and supports the broad-based growth narrative. The trajectory implies a full-year 2026 revenue run-rate well above $7 billion and is consistent with consensus revenue estimates of approximately $11.1 billion for the forward period, underscoring that the market expects the growth algorithm to persist rather than mean-revert. Profitability is robust and improving: Q3 2026 net income was $338.4 million (17.1% net margin) on gross profit of $1.170 billion, a 59.2% gross margin that expanded sharply from 48.7% in Q2 2026 and 49.8% in Q3 2025 — a roughly 950-basis-point year-over-year improvement that likely reflects tariff-refund benefits, favorable mix, and pricing. Operating income of $442.9 million produced a 22.4% operating margin, up from 16.6% a year earlier, while trailing-twelve-month figures show a 49.0% gross margin, 14.4% operating margin, and 11.0% net margin, indicating the quarterly surge is above the run-rate but the underlying trend is clearly upward. The Q2 2026 dip to a 7.4% net margin (versus 17.1% in Q3) illustrates seasonality and cost timing rather than deterioration, and the company has been consistently profitable every quarter in the dataset, with EPS of $2.40 in Q3 2026 versus $1.34 a year earlier. The balance sheet is conservatively managed: debt-to-equity of 0.337, a current ratio of 2.04, and interest coverage above 40x in Q3 2026 ($442.9 million operating income against $11.0 million interest expense) leave ample financial flexibility. Cash generation is the one blemish — Q3 2026 operating cash flow was -$168.1 million and free cash flow -$209.7 million due to a $632.1 million working-capital build (receivables up $534.5 million and inventory up $294.8 million ahead of the holiday season), though trailing-twelve-month free cash flow remains positive at $506.1 million and Q2 2026 generated $431.8 million of operating cash flow. ROE of 26.2% and ROA of 12.6% confirm high returns on capital, and with no dividend (payout ratio of 0) and modest buybacks ($50.5 million in Q3), the company retains earnings to fund growth internally rather than relying on external financing.
Quarterly Revenue
$2.0B
2026-09
Revenue YoY Growth
+21.2%
YoY Comparison
Gross Margin
59.2%
Latest Quarter
Free Cash Flow
$506074000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SN Overvalued?
Because net income is solidly positive ($338.4 million in Q3 2026 alone), the PE ratio is the appropriate primary metric: the stock trades at 22.5x trailing earnings and 28.1x forward earnings, an unusual configuration in which the forward multiple exceeds the trailing multiple. That inversion implies the market expects earnings to normalize lower from the tariff-refund-boosted Q3 level, or that the trailing figure is flattered by a one-time benefit — a nuance investors should weigh against the 0.39 PEG ratio, which on growth-adjusted terms frames the stock as inexpensive. The 2.47x price-to-sales ratio and 4.39x EV/sales look modest for a company growing revenue above 20%, while the 14.6x EV/EBITDA is reasonable for a consumer franchise with expanding margins, though the 24.9x price-to-cash-flow ratio is elevated given the working-capital-driven cash flow volatility. Peer comparison is constrained by the absence of an explicit industry-average multiple in the provided valuation data, but the internal spread is instructive: a 22.5x trailing PE against a 28.1x forward PE and a 0.39 PEG implies the market is paying a growth premium that is small relative to the earnings growth rate, and the 5.89x price-to-book against a 26.2% ROE is consistent with a quality compounder rather than a deep-value name. On a relative basis, the stock's 2.47x PS is well below its own historical peak of 12.85x reported at Q3 2026 in the historical ratios (a figure distorted by a much smaller share count/market-cap basis in that dataset), so the current multiple should be read against the more stable 7.5x–12.8x PS band seen through 2025–2026 rather than taken at face value. Historical context shows meaningful multiple compression alongside the price appreciation: the PE ratio was 41.4x at Q2 2026, 30.8x at Q1 2026, and 18.8x at Q3 2026, meaning earnings have grown faster than the share price and the stock is now cheaper on trailing earnings than it was earlier in the year. That pattern — a rising price with a falling PE — is the signature of earnings-driven rather than multiple-driven returns, which is generally a healthier setup, though it also means the current 22.5x trailing PE sits near the lower end of the stock's own recent band and leaves room for re-rating if growth persists. The risk is that the Q3 margin surge proves transient; if gross margin reverts toward the 49% run-rate, trailing EPS would fall and the effective multiple would rise, so the forward PE of 28.1x is arguably the more honest anchor for valuation.
PE
22.5x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 15x~41x
vs. Industry Avg
24.3x
Industry PE ~24.3x*
EV/EBITDA
14.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on the durability of the Q3 margin surge and cash conversion. Gross margin jumped to 59.2% from 49.8% YoY, but the company itself attributes part of this to a one-time tariff refund, and the TTM gross margin of 49.0% is the more representative run-rate — a reversion would cut trailing EPS materially and push the effective PE well above 22.5x. Q3 2026 operating cash flow was -$168.1 million and free cash flow -$209.7 million on a $632.1 million working-capital build (receivables +$534.5M, inventory +$294.8M), and the 24.9x price-to-cash-flow ratio leaves little room for further cash-flow volatility. Revenue is also concentrated in the U.S. market, exposing results to domestic consumer spending and tariff policy, while the 7.4% net margin in Q2 2026 versus 17.1% in Q3 shows earnings can swing sharply quarter to quarter. Market and competitive risks stem from valuation positioning and momentum dependence. At $222.95 the stock trades at 98.0% of its 52-week range with only +3.6% upside to the $230.91 average target, so any disappointment has an outsized effect; the $195.67 low target sits ~12% below the current price. The forward PE of 28.1x exceeding the trailing 22.5x signals the market already prices normalization, and with a beta of 1.171 the stock is ~17% more volatile than the market. Competitive pressure in small appliances is intense, and the reliance on social commerce and younger-customer traction — while a genuine tailwind per recent coverage — is unproven through a full consumer downturn. The worst-case scenario is a chain in which Q4 results show gross margin reverting toward the high-40s as the tariff refund laps, revenue growth decelerates below 15%, and the working-capital build persists into negative full-year free cash flow, prompting analysts to cut targets toward the $195.67 low. From $222.95 that implies roughly -12%, and a broader momentum unwind toward the September low of $160.80 would imply about -28%; the 25.7% max drawdown already observed in the past year is a realistic stress case, while the $83.21 52-week low is functionally irrelevant as near-term support.
FAQ
Ranked by severity, the first risk is margin durability: gross margin jumped to 59.2% from 49.8% YoY, but part of that reflects a one-time tariff refund, and the 49.0% TTM run-rate is the more representative base — reversion would cut trailing EPS and lift the effective multiple above 22.5x. Second is cash conversion: Q3 operating cash flow was -$168.1 million and free cash flow -$209.7 million on a $632.1 million working-capital build, leaving the 24.9x price-to-cash-flow ratio exposed if the build does not reverse in Q4. Third is positioning and momentum: at 98.0% of the 52-week range with only +3.6% upside to the average target, a beta of 1.171, and a 25.7% max drawdown already seen in September, the stock has no margin of safety and is vulnerable to a momentum unwind in a weak tape (SPY -4.99% over one month). Fourth is concentration and macro: the majority of revenue comes from the U.S. market, exposing results to domestic consumer spending and tariff policy, while quarterly profitability is volatile (7.4% net margin in Q2 2026 versus 17.1% in Q3).
The 12-month forecast is split into three scenarios. The base case carries 55% probability with a $225–$245 range: revenue growth moderates into the high-teens to low-20s, gross margin settles in the mid-50s as the tariff refund laps, and the stock consolidates near the $230.91 average target, with returns tracking EPS growth rather than multiple expansion. The bull case carries 25% probability with a $280–$300 range, requiring gross margin to hold in the high-50s on structural mix and pricing, revenue growth above 20%, and a clean breakout above the $225.69 52-week high toward the $300 high target. The bear case carries 20% probability with a $160–$195.67 range, driven by gross margin reverting toward the high-40s, revenue growth below 15%, and persistent negative free cash flow, with a momentum unwind potentially reaching the $160.80 September low, roughly -28% from $222.95. The base case is most likely, and its key assumption is that the Q3 margin surge is partly transient but the underlying growth algorithm persists.
The answer depends on which earnings base you trust. On trailing earnings SN is modestly undervalued: the PE is 22.5x against a 0.39 PEG, a 2.47x PS, and a 14.6x EV/EBITDA — reasonable multiples for a company growing revenue above 20% with a 26.2% ROE. On forward earnings it is fully valued: the 28.1x forward PE exceeds the 22.5x trailing PE, an inversion that signals the market expects earnings to normalize lower from the tariff-refund-flattered Q3 level. That configuration implies the market is paying a fair-to-full price and expects the margin surge to fade rather than persist. The stock is cheaper than it was earlier in 2026 — the PE was 41.4x at Q2 2026 and 30.8x at Q1 2026 — because earnings grew faster than the share price. Net: fairly valued to modestly undervalued on trailing and growth-adjusted metrics, but fully valued on forward earnings, with the 5.89x price-to-book reflecting quality rather than a discount.
On risk/reward, SN is a qualified yes rather than an unqualified one. The operating evidence is strong — Q3 2026 revenue grew 21.2% to $1.976 billion, gross margin reached 59.2%, net income hit $338.4 million (17.1% margin), and all 14 covering analysts rate it Buy with a 1.14 recommendation mean. The problem is entry price: at $222.95 the stock sits at 98.0% of its 52-week range and the $230.91 average target implies just +3.6% upside, while the $195.67 low target implies roughly -12% downside. The biggest downside risk is margin reversion — if the tariff-refund-boosted 59.2% gross margin falls back toward the 49.0% TTM run-rate, trailing EPS drops and the effective multiple rises above 28x. It is therefore a good buy for growth investors with a multi-year horizon who size positions for a beta of 1.171 and a 25.7% max drawdown, ideally accumulating on pullbacks toward the $190–$200 shelf rather than chasing at the high.
SN is better suited to a long-term holding than to short-term trading, though momentum traders can participate with tight risk controls. The long-term case rests on a genuine growth algorithm — revenue compounding above 20%, a 26.2% ROE, a debt-to-equity of 0.337, a 2.04 current ratio, and >40x interest coverage — that supports a multi-year compounding thesis, and the 0.39 PEG suggests growth is not overpriced. The short-term case is less attractive: the stock is up 20.4% in one month and 142.6% in a year, sits at 98.0% of its 52-week range, and has a beta of 1.171 with a 25.7% max drawdown already observed, so near-term mean reversion risk is elevated. There is no dividend (0% yield, 0 payout ratio), so returns depend entirely on price appreciation and earnings growth. A concrete minimum holding period of 2–3 years is appropriate to ride through quarterly margin volatility and the working-capital cycle, with position sizing that accounts for the amplified drawdown profile.